Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers.

von Willebrand factor (vWF) is a multimeric adhesive glycoprotein with one factor VIII binding site/subunit. Prior reports suggest that posttranslational modifications of vWF, including formation of N-terminal intersubunit disulfide bonds and subsequent cleavage of the propeptide, influence availability and/or affinity of factor VIII binding sites. We found that deletion of the vWF propeptide produced a dimeric vWF molecule lacking N-terminal intersubunit disulfide bonds. This molecule bound fluorescein-labeled factor VIII with sixfold lower affinity than multimeric vWF in an equilibrium flow cytometry assay (approximate KDs, 5 nmol/L v 0.9 nmol/L). Coexpression of propeptide-deleted vWF with the vWF propeptide in trans yielded multimeric vWF that displayed increased affinity for factor VIII. Insertion of an alanine residue at the N-terminus of the mature vWF subunit destroyed binding to factor VIII, indicating that the native mature N-terminus is required for factor VIII binding. The requirement for vWF propeptide cleavage was shown by (1) a point mutation of the vWF propeptide cleavage site yielding pro-vWF that was defective in factor VIII binding and (2) correlation between efficiency of intracellular propeptide cleavage and factor VIII binding. Furthermore, in a cell-free system, addition of the propeptide-cleaving enzyme PACE/furin enabled factor VIII binding in parallel with propeptide cleavage. Our results indicate that high-affinity factor VIII binding sites are located on N-terminal disulfide-linked vWF subunits from which the propeptide has been cleaved.

[1]  E. Saenko,et al.  The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor* , 1997, The Journal of Biological Chemistry.

[2]  J. Sixma,et al.  Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C. , 1996, Blood.

[3]  J. Sixma,et al.  The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. , 1995, Blood.

[4]  D. Wagner,et al.  von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies , 1994 .

[5]  M. Shima,et al.  A role for the C2 domain of factor VIII in binding to von Willebrand factor. , 1994, The Journal of biological chemistry.

[6]  B. Furie,et al.  Membrane binding kinetics of factor VIII indicate a complex binding process. , 1993, The Journal of biological chemistry.

[7]  M. Shima,et al.  A Factor VIII Neutralizing Monoclonal Antibody and a Human Inhibitor Alloantibody Recognizing Epitopes in the C2 Domain Inhibit Factor VIII Binding to von Willebrand Factor and to Phosphatidylserine , 1993, Thrombosis and Haemostasis.

[8]  G. E. Gilbert,et al.  Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). , 1992, The Journal of biological chemistry.

[9]  P. Mannucci,et al.  Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial. , 1992, Blood.

[10]  A. Rehemtulla,et al.  Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. , 1992, Blood.

[11]  T. Mayadas,et al.  Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Bauer,et al.  A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage. , 1992, Blood.

[13]  T. Oegema,et al.  A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion , 1992, The Journal of cell biology.

[14]  J. Sadler.  von Willebrand factor. , 1991, The Journal of biological chemistry.

[15]  A. Dorner,et al.  The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. , 1991, The Journal of biological chemistry.

[16]  A. Giles,et al.  The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. , 1991, The Journal of biological chemistry.

[17]  B. Duim,et al.  The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor. , 1991, The Biochemical journal.

[18]  A. Brake,et al.  Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Esmon Nl,et al.  Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C. , 1990 .

[20]  D. Ginsburg,et al.  A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide. , 1989, The Journal of clinical investigation.

[21]  R. Kaufman,et al.  Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. , 1989, Molecular and cellular biology.

[22]  J. V. van Mourik,et al.  The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. , 1989, The Biochemical journal.

[23]  A. Dorner,et al.  Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. , 1988, The Journal of biological chemistry.

[24]  S. Orkin,et al.  The propeptide of von Willebrand Factor independently mediates the assembly of von Willebrand multimers , 1988, Cell.

[25]  P. Lollar,et al.  Stoichiometry of the porcine factor VIII-von Willebrand factor association. , 1987, The Journal of biological chemistry.

[26]  K. Titani,et al.  Identification of disulfide-bridged substructures within human von Willebrand factor. , 1987, Biochemistry.

[27]  D. Meyer,et al.  Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. , 1987, Blood.

[28]  H. Pannekoek,et al.  Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro‐polypeptide in vWF multimer formation. , 1987, The EMBO journal.

[29]  J. Sixma,et al.  Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain. , 1987, European journal of biochemistry.

[30]  K. Titani,et al.  A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. , 1987, The Journal of biological chemistry.

[31]  D. Bonthron,et al.  Structure of pre-pro-von Willebrand factor and its expression in heterologous cells , 1986, Nature.

[32]  P. Diergaarde,et al.  Full‐length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. , 1986, The EMBO journal.

[33]  K. Titani,et al.  Cloning and characterization of two cDNAs coding for human von Willebrand factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Wagner,et al.  Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization , 1984, The Journal of cell biology.

[35]  D. Livingston,et al.  Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. J. Johnson,et al.  The In Vitro Association of Antihemophilic Factor and von Willebrand Factor , 1983, Thrombosis and Haemostasis.

[37]  E. Tuddenham,et al.  Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease , 1982, British journal of haematology.

[38]  H. Hemker,et al.  The role of phospholipid and factor VIIIa in the activation of bovine factor X. , 1981, The Journal of biological chemistry.

[39]  L. Hoyer,et al.  Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers , 1980 .

[40]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Sixma,et al.  Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII. , 1978, The Journal of clinical investigation.

[42]  I. Sussman,et al.  Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. , 1977, The Journal of clinical investigation.

[43]  D. Wagner,et al.  von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. , 1994, Blood.

[44]  R. Kaufman.  Vectors used for expression in mammalian cells. , 1990, Methods in enzymology.

[45]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[46]  Z. Ruggeri,et al.  The complex multimeric composition of factor VIII/von Willebrand factor. , 1981, Blood.

[47]  L. Hoyer,et al.  Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers. , 1980, Blood.

[48]  I. Sussman,et al.  STUDIES ON POSTTRANSFUSION AND DISSOCIATED FACTOR VIII AND IN PATIENTS WITH VON WILLEBRAND'S DISEASE , 1977 .

[49]  A. Patek,et al.  HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD. , 1937, The Journal of clinical investigation.